Systematic review with meta‐analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth

BACKGROUND: Small intestinal bacterial overgrowth (SIBO) is a heterogeneous syndrome, characterised by an increased number and/or abnormal type of bacteria in the small bowel. Over the past decades, rifaximin has gained popularity for this indication despite its use is not evidence based. AIM: To pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatta, L., Scarpignato, C., McCallum, R.W., Lombardo, L., Pimentel, M., D'Incà, R., Gasbarrini, A., De Stefano, A., Cerda, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Systematic Reviews with Meta‐analyses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299503/
https://www.ncbi.nlm.nih.gov/pubmed/28078798
http://dx.doi.org/10.1111/apt.13928

Ejemplares similares

Ejemplares similares